Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes

Journal of Inflammation (United Kingdom)

Volumn 9, Issue , 2012, Pages

  Hijdra, Daniëlle ^a   Vorselaars, Adriane Dm ^a   Grutters, Jan C ^a,b   Claessen, Anke Me ^a   Rijkers, Ger T ^a,c  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Roosevelt Academy   (Netherlands)

Author keywords

CD120a; CD120b; CD14; CD16; HLA DR; Monocytes; Peripheral blood; Sarcoidosis; TNF receptor

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; SARCOIDOSIS;

EID: 84867025709     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-38     Document Type: Article

References (25)

1. Migratory fate and differentiation of blood monocyte subsets. Tacke F, Randolph GJ, Immunobiology 2006 211 609 618 10.1016/j.imbio.2006.05.025 16920499
2. Nomenclature of monocytes and dendritic cells in blood. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB, Blood 2010 116 74 e80 10.1182/blood-2010-02- 258558 20628149
3. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Wong KL, Tai JJY, Wong WC, Han H, Sem X, Yeap WH, Kourilsky P, Wong SC, Blood 2011 118 16 e31 10.1182/blood-2010-12-326355 21653326
4. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, Heine GH, Blood 2011 118 50 61 10.1182/blood-2011-01-326827 21803849
5. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. Ziegler-Heitbrock L, J Leukoc Biol 2007 81 584 592 17135573 (Pubitemid 46393535)
6. Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis. Heron M, Grutters JC, van Velzen-Blad H, Veltkamp M, Claessen AM, van den Bosch JM, Chest 2008 134 1001 1008 10.1378/chest.08-0443 18641108
7. Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients. Okamoto H, Mizuno K, Horio T, J Dermatol 2003 30 503 509 12928539 (Pubitemid 36950762)
8. The CD14brightCD16+ monocyte subset is expanded in rheumatoid arthritis and promotes Th17 expansion. Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U, Arthritis Rheum 2012 64 671 677 10.1002/art.33418 22006178
9. Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients. Moniuszko M, Bodzenta-Lukaszyk A, Kowal K, Lenczewska D, Dabrowska M, Clin Immunol 2009 130 338 346 10.1016/j.clim.2008.09.011 18952503
10. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Statement on sarcoidosis, Am J Respir Crit Care Med 1999 160 736 755 10430755
11. Sarcoidosis. Grutters JC, Drent M, van den Bosch JJM, Eur Resp Mon 2009 46 126 154
12. Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Baughman RP, Nagai S, Balter M, Costabel U, Drent M, du Bois R, Grutters JC, Judson MA, Lambiri I, Lower EE, Muller-Quernheim J, Prasse A, Rizzato G, Rottoli P, Spagnolo P, Teirstein A, Sarcoidosis Vasc Diffuse Lung Dis 2011 28 56 64 21796892
13. Pulmonary sarcoidosis in the Nordic countries 1950-1982. Milman N, Selroos O, Epidemiology and clinical picture. Sarcoidosis 1990 7 50 57
14. Sarcoidosis: changing insights in therapy. Kamphuis LS, van Laar JA, Kuijpers RW, Missotten T, Thio HB, van Hagen PM, Ned Tijdschr Geneeskd 2010 154 1685 21118599
15. Clinical characteristics of patients in a case control study of sarcoidosis. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R, Am J Respir Crit Care Med 2001 164 1885 1889 11734441 (Pubitemid 33152325)
16. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis. Fehrenbach H, Zissel G, Goldmann T, Tschernig T, Vollmer E, Pabst R, Müller-Quernheim J, Eur Respir J 2003 21 421 428 10.1183/09031936.03.00083002 12661995 (Pubitemid 36336199)
17. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. Baughman RP, Strohofer SA, Buchsbaum J, Lower EE, J Lab Clin Med 1990 115 36 42 2299255 (Pubitemid 20044133)
18. Expression of membrane receptor for tumour necrosis factor on human blood lymphocytes. Zola H, Flego L, Weedon H, Immunol Cell Biol 1993 71 281 288 10.1038/icb.1993.33 7901149 (Pubitemid 23253519)
19. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. Gehr G, Gentz R, Brockhaus M, Loetscher H, Lesslauer W, J Immunol 1992 149 911 917 1321854
20. Increased expression of tumor necrosis factor receptors in cryptogenic organizing pneumonia. Ye Q, Dai H, Sarria R, Guzman J, Costabel U, Respir Med 2011 105 292 297 10.1016/j.rmed.2010.10.022 21144722
21. TNF receptor 2 pathway: drug target for autoimmune diseases. Faustman D, Davis M, Nat Rev Drug Discov 2010 9 482 493 10.1038/nrd3030 20489699
22. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D, J Exp Med 1992 175 323 329 10.1084/jem.175.2.323 1310100
23. Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis. Kieszko R, Krawczyk P, Chocholska S, Bojarska-Junak A, Jankowska O, Król A, Roliński J, Milanowski J, Respir Med 2007 101 645 654 10.1016/j.rmed.2006.06.004 16889950 (Pubitemid 46196314)
24. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. Fotin-Mleczek M, Henkler F, Samel D, Reichwein M, Hausser A, Parmryd I, Scheurich P, Schmid JA, Wajant H, J Cell Sci 2002 115 2757 2770 12077366 (Pubitemid 34846516)
25. Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators. Van Mierlo GJ, Scherer HU, Hameetman M, Morgan ME, Flierman R, Huizinga TW, Toes RE, J Immunol 2008 180 2747 2751 18292492